Back to Awarded Treatment Trials
Awarded Trial: 14T-007
Grant ID
14T-007
Illness
Schizophrenia
Primary Drug/Intervention
Garcinia mangostana Linn (mangosteen) pericarp
Primary Dosage
1000 mg daily
Secondary Drug Intervention
antipsychotic drug treatment
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Berk
Sample Size
150
Duration of Study Period for Each Subject
168 days
Outcome Measurements
N/A
Results
N/A
Publication
N/A
Link
N/A
PI Name
Michael Berk
Degree
MD, PhD
Center
School of Medicine
Institution
Deakin University
Address
PO Box 281
City or Town
Geelong
State or Province
VIC
Zip or Postal Code
3220
Country
Australia
Email Address
mikebe@barwonhealth.org.au